U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

ATRACTYLODES MACROCEPHALA WHOLE

MORE DETAILS

61Q25TS7LH

structurally diverse
Status:
Possibly Marketed Outside US
Source:
M028
(2023)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0740e366-17ab-d3fa-e063-6294a90ae3e9
First approved in 2023
Source:
Rhinitis Yituling by Sanfutang Traditional Chinese Medicine Investment (Yunnan) Co., Ltd
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=017262ec-1b29-b6d5-e063-6394a90aded7
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966